Antimicrobial susceptibility of Bartonella henselae using Etest methodology

被引:21
作者
Pendle, S [1 ]
Ginn, A [1 ]
Iredell, J [1 ]
机构
[1] Univ Sydney, Westmead Hosp, Ctr Infect Dis & Microbiol, Westmead, NSW 2145, Australia
关键词
Bartonella spp; B; henselae; antimicrobial resistance; susceptibility testing;
D O I
10.1093/jac/dki485
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Bartonella henselae is a fastidious slow growing pathogen which is seldom cultured in the laboratory. Previous descriptions of antimicrobial susceptibility have been largely limited to feline isolates and/or laboratory reference strains, with no accounting for genotypic or phenotypic diversity. Methods: An optimal method of antimicrobial susceptibility testing by Etest was established to compare the antimicrobial susceptibilities of 12 different isolates of B. henselae, 5 human and 7 feline, which have previously been well characterized by 16S rRNA sequencing, multi-locus sequence typing (MLST), phase variation and passage number. Results: No difference in susceptibility could be attributed to differences in genotype, source of the isolate or passage number. Where comparisons were drawn with previously published results, these were found to be concordant. Conclusions: We conclude that antibiotic susceptibility can be determined by a simple Etest method for B. henselae isolates. This method is reproducible among diverse strains, and is sufficiently predictable that generalizations can be confidently made about optimal antibiotic choices.
引用
收藏
页码:761 / 763
页数:3
相关论文
共 9 条
[1]   Bartonella spp. as emerging human pathogens [J].
Anderson, BE ;
Neuman, MA .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (02) :203-+
[2]   BARTONELLA-HENSELAE AND BARTONELLA-QUINTANA ADHERENCE TO AND ENTRY INTO CULTURED HUMAN EPITHELIAL-CELLS [J].
BATTERMAN, HJ ;
PEEK, JA ;
LOUTIT, JS ;
FALKOW, S ;
TOMPKINS, LS .
INFECTION AND IMMUNITY, 1995, 63 (11) :4553-4556
[3]   Characterization of the natural population of Bartonella henselae by multilocus sequence typing [J].
Iredell, J ;
Blanckenberg, D ;
Arvand, M ;
Grauling, S ;
Feil, EJ ;
Birtles, RJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (11) :5071-5079
[4]   In vitro susceptibilities of Bartonella henselae, B-quintana, B-elizabethae, Rickettsia rickettsii, R-conorii, R-akari, and R-prowazekii to macrolide antibiotics as determined by immunofluorescent-antibody analysis of infected vero cell monolayers [J].
Ives, TJ ;
Manzewitsch, P ;
Regnery, RL ;
Butts, JD ;
Kebede, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :578-582
[5]   In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers [J].
Ives, TJ ;
Marston, EL ;
Regnery, RL ;
Butts, JD .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (03) :217-222
[6]   Phase variation in Bartonella henselae [J].
Kyme, P ;
Dillon, B ;
Iredell, J .
MICROBIOLOGY-SGM, 2003, 149 :621-629
[7]   MICS OF 28 ANTIBIOTIC COMPOUNDS FOR 14 BARTONELLA (FORMERLY ROCHALIMAEA) ISOLATES [J].
MAURIN, M ;
GASQUET, S ;
DUCCO, C ;
RAOULT, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2387-2391
[8]   Recommendations for treatment of human infections caused by Bartonella species [J].
Rolain, JM ;
Brouqui, P ;
Koehler, JE ;
Maguina, C ;
Dolan, MJ ;
Raoult, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :1921-1933
[9]   The Etest for antimicrobial susceptibility testing of Bartonella henselae [J].
Wolfson, C ;
Branley, J ;
Gottlieb, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (06) :963-968